Experience with maintenance rituximab after chemotherapy in patients with low-grade lymphoma

Ayodele Ayoola; Mercedes Terrell; Huzefa Bahrain; Patricia Ford; Michael Auerbach

doi:10.1016/S1548-5315(11)70416-8

Experience with maintenance rituximab after chemotherapy in patients with low-grade lymphoma

Ayodele Ayoola
, Mercedes Terrell
, Huzefa Bahrain
, Patricia Ford
, Michael Auerbach

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

In this retrospective analysis of 21 previously untreated patients, long-term rituximab maintenance therapy following R-CHOP chemotherapy was well tolerated and resulted in prolonged progression-free survival, with no relapses.

Original language	English (US)
Pages (from-to)	414-417
Number of pages	4
Journal	Community Oncology
Volume	7
Issue number	9
DOIs	https://doi.org/10.1016/S1548-5315(11)70416-8
State	Published - Sep 2010

All Science Journal Classification (ASJC) codes

Hematology
Oncology

Access to Document

10.1016/S1548-5315(11)70416-8

Cite this

@article{bc25328a79994a20b02f3b6f129d6290,

title = "Experience with maintenance rituximab after chemotherapy in patients with low-grade lymphoma",

abstract = "In this retrospective analysis of 21 previously untreated patients, long-term rituximab maintenance therapy following R-CHOP chemotherapy was well tolerated and resulted in prolonged progression-free survival, with no relapses.",

author = "Ayodele Ayoola and Mercedes Terrell and Huzefa Bahrain and Patricia Ford and Michael Auerbach",

year = "2010",

month = sep,

doi = "10.1016/S1548-5315(11)70416-8",

language = "English (US)",

volume = "7",

pages = "414--417",

journal = "Community Oncology",

issn = "1548-5315",

publisher = "BioLink Communications",

number = "9",

}

TY - JOUR

T1 - Experience with maintenance rituximab after chemotherapy in patients with low-grade lymphoma

AU - Ayoola, Ayodele

AU - Terrell, Mercedes

AU - Bahrain, Huzefa

AU - Ford, Patricia

AU - Auerbach, Michael

PY - 2010/9

Y1 - 2010/9

N2 - In this retrospective analysis of 21 previously untreated patients, long-term rituximab maintenance therapy following R-CHOP chemotherapy was well tolerated and resulted in prolonged progression-free survival, with no relapses.

AB - In this retrospective analysis of 21 previously untreated patients, long-term rituximab maintenance therapy following R-CHOP chemotherapy was well tolerated and resulted in prolonged progression-free survival, with no relapses.

UR - https://www.scopus.com/pages/publications/78549269129

UR - https://www.scopus.com/pages/publications/78549269129#tab=citedBy

U2 - 10.1016/S1548-5315(11)70416-8

DO - 10.1016/S1548-5315(11)70416-8

M3 - Article

AN - SCOPUS:78549269129

SN - 1548-5315

VL - 7

SP - 414

EP - 417

JO - Community Oncology

JF - Community Oncology

IS - 9

ER -

Experience with maintenance rituximab after chemotherapy in patients with low-grade lymphoma

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this